Associations of genetic variants of lysophosphatidylcholine metabolic enzymes with levels of serum lipids.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 33935285.
- Also identified by DOI 10.1038/s41390-021-01549-9.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Metabolic disturbance of lysophosphatidylcholine (LPC) is related with dyslipidemia. Therefore, eight single-nucleotide polymorphisms (SNPs) were selected from LPC metabolic enzymes to study their associations with obesity and serum levels of lipids. A total of 3305 children were recruited from four independent studies. Eight SNPs of LPC metabolic enzymes were selected and genotyped with the matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS). The multivariable linear regression model was applied to detect the associations of eight SNPs with obesity-related phenotypes and levels of lipids in each study. Meta-analyses were used to combine the results of four studies. Only SNP rs4420638 of APOC-1 gene was associated with serum lipids even after Bonferroni correction. The rs4420638 was positively associated with TC (β = 0.15, P = 8.59 × 10<sup>-9</sup>) and low-density-lipoprotein-cholesterol (LDL-C, β = 0.16, P = 9.98 × 10<sup>-14</sup>) individually. The study firstly revealed the association between APOC-1/rs4420638 and levels of serum lipids in Chinese children, providing evidence for susceptible gene variants of dyslipidemia.
Medical subject headings
- Apolipoprotein C-I
- Dyslipidemias
- Lysophosphatidylcholines